Latest Breaking News On - Geovax - Page 1 : comparemela.com

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

80% Survival in Nonhuman Primates Observed in a Lethal Challenge Model ATLANTA, GA, Nov. 30, 2023 (GLOBE NEWSWIRE) via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the presentation of data from recent preclinical studies of its vaccine candidates against Marburg virus and Sudan virus. The data were presented during the World Vaccine Congress, West Coast conference, bein

Mark newmanSanta claraNational institute of allergyCompany contactUniversity of texas medical branch at galvestonDepartment of microbiologyPreclinical servicesWorld vaccine congressGeovax labs incNonhuman primates observedLethal challengeGeovax labsWest coastJason comerAssociate professorTexas medical branch

GeoVax Secures Multi-Product License for ProBioGen s

ATLANTA, GA and BERLIN, Germany, Sept. 26, 2023 (GLOBE NEWSWIRE) via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company.

Gabriele schneiderSusan robertsLisa petereitVolker sandigDavid doddGeovax press contactProbiogen press contactGeovax labs incCorporate communicationsGeovax labsModified vaccinia ankaraCell lineVax labsBiogen contactBiogen press contactVax contact

GeoVax Appoints Recognized Industry Leader John W Sharkey,

Operational Resources Strengthened to Support Company Growth and Development Atlanta, GA, June 13, 2022 (GLOBE NEWSWIRE) via NewMediaWire.

Johnw sharkeyDavid doddUniversity of new york at oneontaDrug administrationOperational resources strengthened to support company growthLargent healthCogas consultingNewmediawire geovax labs incBusiness development for geovaxGeovax labs incUniversity of buffaloNovartis pharmaceuticals corporationCompany head of business developmentShionogi pharmaceuticals incBusiness developmentOperational resources strengthened

GeoVax Reports 2021 Year-End Financial Results and Provides

Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology ATLANTA, GA, March 09, 2022 (GLOBE NEWSWIRE) via NewMediaWire GeoVax.

National cancer instituteEmory universityDrug administrationGeovax labs incTherapeutics incProducts clinical trials grants programStanford universityAdvancing phaseGeovax labsStandard timeTrials underwayImmunocompromised patientsBooster vaccineEnabling activities progressingJapan coronavirus vaccineTrial underway

GeoVax to Participate in the Alliance Global Partners Virtual Healthcare Symposium

GeoVax to Participate in the Alliance Global Partners Virtual Healthcare Symposium
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Newmediawire geovax labsInfectious diseasesGeovax labsTherapeutic vaccinesPreventive vaccines